Skip to main content
Enterprise AI Analysis: Machine learning prediction of live birth after IVF using the morphological uterus sonographic assessment group features of adenomyosis

Enterprise AI Analysis

Machine learning prediction of live birth after IVF using the morphological uterus sonographic assessment group features of adenomyosis

This AI analysis provides an executive overview of a pioneering study leveraging Machine Learning (ML) to predict live birth rates after IVF/ICSI, specifically incorporating advanced morphological uterus sonographic assessment (MUSA) features for adenomyosis. Our findings highlight the critical role of ovarian reserve and certain uterine characteristics in improving prediction accuracy, offering actionable insights for reproductive clinics.

Executive Impact: Key Metrics & AI Advantages

Our AI models distill complex research into actionable metrics, providing your enterprise with a clear understanding of the potential for enhanced precision and efficiency in IVF prognostics. This study achieved a test AUC of 0.66, demonstrating valuable predictive power for live birth outcomes.

0.0 Test AUC for Live Birth Prediction
0.0 Key Predictor: AMH
0 Study Cohort Size

Deep Analysis & Enterprise Applications

Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.

Machine Learning in ART
Adenomyosis Impact
Ovarian Reserve & Uterine Factors

This research exemplifies the growing application of advanced machine learning algorithms, specifically XGBoost, in Assisted Reproductive Technology (ART). By analyzing complex, non-linear relationships within vast datasets, ML models aim to provide more accurate and personalized prognostics compared to traditional statistical methods. The study validates ML's potential for identifying nuanced predictors of live birth in IVF/ICSI, particularly when integrating detailed sonographic features.

Adenomyosis, characterized by ectopic endometrial tissue within the myometrium, is a significant factor in subfertility and ART outcomes. The study utilized the revised Morphological Uterus Sonographic Assessment (MUSA) group features to diagnose and categorize adenomyosis. While MUSA features contribute to the model, their predictive ability for live birth was found to be limited when considered in isolation, emphasizing the multifactorial nature of IVF success.

The analysis underscores the paramount importance of ovarian reserve parameters, such as s-AMH and AFC, as primary predictors of live birth. A regular junctional zone (JZ), indicative of preserved myometrial architecture, also emerged as a key ultrasonographic variable. This highlights that while uterine pathology like adenomyosis plays a role, the quantity and quality of oocytes remain dominant determinants of IVF success.

Key AI Prediction Metric

0.66 Test AUC for Live Birth Prediction

The XGBoost model achieved a test Area Under the Receiver Operating Characteristics Curve (AUC) of 0.66, indicating modest but valuable predictive performance for live birth after the first IVF/ICSI treatment. This metric reflects the model's ability to distinguish between patients who will achieve live birth and those who will not.

IVF/ICSI Prediction Model Development Workflow

Data Collection (1037 Women)
TVUS & s-AMH Assessment
Feature Engineering (MUSA, Symptoms)
Data Split (80% Train, 20% Test)
XGBoost Model Training & Tuning
SHAP Variable Importance Analysis
Live Birth Prediction & Evaluation (AUC 0.66)

Predictive Power of Key Variables

Variable Category Key Findings & Impact
Ovarian Reserve
  • s-AMH (mean SHAP 0.21) identified as the strongest predictor.
  • AFC also a significant predictor, reflecting oocyte availability.
Uterine Morphology
  • Regular JZ (mean SHAP 0.13) is the best ultrasonographic predictor.
  • Interrupted JZ on 3D (mean SHAP 0.057) shows some predictive value.
  • Direct MUSA features (lines and buds, mean SHAP 0.007) had limited predictive ability.
Clinical Symptoms
  • Dysmenorrhea, dyspareunia, pelvic pain, dyschezia, dysuria, hematuria, and hematochezia showed negligible contribution.
Treatment Factors (Post-Hoc)
  • Embryo stage (blastocyst, cleavage) and FET significantly improved model performance (AUC 0.75).
  • These factors emerged as dominant predictors when included.

Enhancing Patient Counseling with AI Insights

A 32-year-old patient with unexplained infertility and a regular JZ on TVUS, but low s-AMH levels, is considering her first IVF treatment. Traditional counseling might focus heavily on the uterine assessment. With AI insights, the clinic can provide a more nuanced prognosis, emphasizing that her low s-AMH (a high SHAP value predictor) significantly impacts her chances, while the regular JZ is a positive but less dominant factor. This allows for a more realistic expectation setting and personalized treatment strategy, potentially guiding decisions around oocyte retrieval protocols or early consideration of multiple cycles.

Calculate Your Clinic's Potential Efficiency Gains

Estimate the potential annual savings and reclaimed clinical hours by integrating an AI-driven live birth prediction model into your IVF/ICSI workflow. Improved prognostication can streamline patient management, optimize resource allocation, and reduce emotional burden from unsuccessful cycles.

Estimated Annual Savings $0
Reclaimed Annual Hours 0

Your AI Implementation Roadmap

We guide you through a structured, three-phase process to seamlessly integrate advanced AI into your IVF/ICSI prognostication, ensuring a smooth transition and measurable impact.

Phase 1: Data Integration & Model Customization

Establish secure pipelines for integrating existing patient data (s-AMH, AFC, TVUS features, clinical history) into the AI platform. Customize the XGBoost model to your clinic's specific patient demographics and treatment protocols. Initial validation with retrospective data.

Phase 2: Pilot Deployment & Clinician Training

Deploy the AI model in a pilot phase, running alongside current prognostication methods. Train clinicians on interpreting AI-generated predictions and SHAP values for patient counseling. Gather feedback on usability and perceived accuracy.

Phase 3: Full Integration & Continuous Improvement

Integrate the AI model into the clinical decision-making workflow. Continuously monitor model performance against actual live birth outcomes. Retrain and refine the model with new data to improve predictive accuracy and adapt to evolving clinical practices.

Ready to Transform Your IVF Clinic with AI?

Discover how our AI-driven prediction models can enhance patient counseling, optimize treatment strategies, and improve live birth outcomes. Schedule a personalized consultation with our experts to explore a tailored implementation plan for your practice.

Ready to Get Started?

Book Your Free Consultation.

Let's Discuss Your AI Strategy!

Lets Discuss Your Needs


AI Consultation Booking